Literature DB >> 31590909

Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease.

Aneesha Thobani1, Devinder S Dhindsa2, Benjamin D DeMoss2, Mohamad Raad1, Pratik B Sandesara2, Laurence S Sperling3, Jefferson T Baer2.   

Abstract

Aspirin use in the prevention of cardiovascular events has been a mainstay of treatment for decades. However, the use of aspirin in primary prevention of atherosclerotic cardiovascular disease has recently come under scrutiny. Several recent studies have evaluated the use of aspirin in primary prevention and the results suggest that in many patients the risks may outweigh the benefits. Closer examination of these trials suggests that the use of aspirin therapy for primary prevention may have a role but likely needs a more tailored approach and that caution is needed in prescribing aspirin for primary prevention. In conclusion, in this article we review the evolving evidence for aspirin in the primary prevention of atherosclerotic cardiovascular disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31590909     DOI: 10.1016/j.amjcard.2019.08.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study.

Authors:  Lauren H Theilen; Philip Greenland; Jasmina Varagic; Janet Catov; Anthony Shanks; Vanessa Thorsten; Corette B Parker; Rebecca McNeil; Brian Mercer; Matthew Hoffman; Ronald Wapner; David Haas; Hyagriv Simhan; William Grobman; Judith H Chung; Lisa D Levine; Shannon Barnes; Noel Bairey Merz; George Saade; Robert M Silver
Journal:  Pregnancy Hypertens       Date:  2022-02-04       Impact factor: 2.494

Review 2.  The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach.

Authors:  Zlatko Fras; Amirhossein Sahebkar; Maciej Banach
Journal:  Am J Cardiovasc Drugs       Date:  2021-03       Impact factor: 3.571

3.  Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study.

Authors:  Yuki Imaoka; Masahiro Ohira; Koki Sato; Kouki Imaoka; Shintaro Kuroda; Hiroyuki Tahara; Tsuyoshi Kobayashi; Kentaro Ide; Yuka Tanaka; Hideki Ohdan
Journal:  Ann Gastroenterol Surg       Date:  2021-09-19

Review 4.  Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.

Authors:  Esha Sehanobish; Mohammad Asad; Mali Barbi; Steven A Porcelli; Elina Jerschow
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.